COLL vs ICE · P/E 17, rev $181.9M vs P/E 37, rev $12.64B
Collegium Pharmaceutical Inc (COLL) versus Intercontinental Exchange Inc (ICE) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported ICE revenue for 2025-12-31 was $12.64B. Net income was $3.31B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Not investment advice. Open the COLL and ICE stock pages for the full models.
Not investment advice.